D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer
A phase 3 trial testing D07001 in biliary tract cancer, now recruiting.
Overview
D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer is a phase 3 interventional study registered as NCT06622057, led by InnoPharmax, and recruiting when checked on 2026-09-11. Official title: Phase III, Randomised, Double-blind Study of Combination Therapy With D07001-Softgel Capsules and Capecitabine vs Placebo and Capecitabine in Patients With Advanced BTC After Failed on Gemcitabine, Platin, and FOLFOX or Irinotecan Regimens. Planned enrolment is 240 participants (estimated). The study started in 2026-06-09 and primary completion is expected in 2028-12-31. No results have been posted on ClinicalTrials.gov.
Similar pages
not linked directly; found by shared links- TrialStudy of Combination Therapy of D07001-Softgel Capsules and Xeloda/TS-1 in Subjects With Advanced Biliary Tract Cancer
Shares D07001, Biliary tract cancer (cholangiocarcinoma) and the tag ctgov-ingest.
- TrialA Phase III Study of SHR-8068 in Combination With Adebrelimab and Platinum-Containing Chemotherapy Versus Durvalumab in Combination With Platinum-Containing Chemotherapy as First-line Treatment for Advanced Biliary Tract Cancer (BTC)
Shares Biliary tract cancer (cholangiocarcinoma) and the tag ctgov-ingest.
- TrialA Clinical Study of TQB3454 Tablets in the Treatment of Advanced Biliary Carcinoma
Shares Biliary tract cancer (cholangiocarcinoma) and the tag ctgov-ingest.
- TrialHMPL-453 Tartrate in Advanced Intrahepatic Cholangiocarcinoma
Shares Biliary tract cancer (cholangiocarcinoma) and the tag ctgov-ingest.
- TrialA Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)
Shares Biliary tract cancer (cholangiocarcinoma) and the tag ctgov-ingest.
- TreatmentCGT4859
Shares Biliary tract cancer (cholangiocarcinoma) and the tag ctgov-ingest.
- TreatmentAZD4360
Shares Biliary tract cancer (cholangiocarcinoma) and the tag ctgov-ingest.
- TreatmentSpevatamig
Shares Biliary tract cancer (cholangiocarcinoma) and the tag ctgov-ingest.